Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
19.93
+0.57 (2.94%)
At close: May 12, 2025, 4:00 PM
19.78
-0.15 (-0.75%)
After-hours: May 12, 2025, 4:05 PM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $12.23 billion as of May 12, 2025. Its market cap has decreased by -34.97% in one year.
Market Cap
12.23B
Enterprise Value
11.77B
1-Year Change
-34.97%
Ranking
Category
Stock Price
$19.93
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $12.23B, an increase of 2,809.03%. That is a compound annual growth rate of 29.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 12.82B | -7.21% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |